Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can sustained cortisol excess contribute to insulin resistance?

Sustained cortisol excess can impair insulin action and contribute to insulin resistance, although the effects of ordinary stress-related cortisol variation remain uncertain.

PlausibleNovember 21, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Chronic HPA-axis activation and elevated cortisol signaling can impair insulin action and contribute to insulin resistance.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Cortisol excess reduces glucose uptake in peripheral tissues and impairs insulin's suppression of liver glucose production. Evidence is strongest for pathological cortisol excess and glucocorticoid medications, not everyday stress-related cortisol changes.

Verified conclusion

Chronic, sustained cortisol excess is a biologically and clinically established cause of impaired insulin responsiveness. The strongest evidence concerns endogenous hypercortisolism (particularly Cushing syndrome) and pharmacologic glucocorticoid exposure, rather than ordinary day-to-day stress-related cortisol variation.

Clinical and physiological evidence

  • Human hyperinsulinemic–euglycemic clamp studies in hypercortisolism show reduced insulin-stimulated peripheral glucose disposal and impaired insulin-mediated suppression of hepatic glucose production. Thus, cortisol excess affects both peripheral insulin sensitivity—especially in muscle—and hepatic control of glucose output.
  • Treatment of endogenous hypercortisolism improves glycemic control, and glucocorticoid-receptor blockade has improved HbA1c in people with hypercortisolism and difficult-to-control type 2 diabetes. These findings support a directional role for cortisol signaling, not simply an association with hyperglycemia.
  • Cortisol excess may also impair insulin secretion, although some individuals initially develop compensatory hyperinsulinemia.

Mechanistic basis

  • Proposed mechanisms include disruption of IRS-1/PI3K/Akt insulin-signaling pathways, reduced GLUT4 translocation and cellular glucose uptake, increased hepatic gluconeogenesis, and lipolysis-associated elevations in circulating free fatty acids.
  • These mechanisms align with the observed clamp phenotype: less glucose entering insulin-responsive peripheral tissue and inadequate insulin suppression of liver glucose production.

Clinical interpretation

  • Metabolic recovery after correction of hypercortisolism can be incomplete, potentially reflecting residual visceral adiposity and other cardiometabolic consequences of prolonged exposure.
  • These findings should not be directly equated with a single high morning cortisol result or modest cortisol changes associated with everyday perceived stress; studies using stress measures, cortisol biomarkers, and HOMA-IR are heterogeneous and do not establish comparable causality.

Bottom line

  • Chronic, substantial elevation of cortisol signaling can impair insulin action and contribute to insulin resistance; this is strongly supported in pathological or pharmacologic glucocorticoid excess, while the effect size for ordinary physiologic HPA-axis variation remains uncertain.

References

  1. Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review — pmc.ncbi.nlm.nih.gov ↗
  2. Glucose Metabolism in Cushing Syndrome - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  3. Breaking Through Difficult-to-Control T2D: Targeting Hypercortisolism — pmc.ncbi.nlm.nih.gov ↗
  4. Mechanisms of Glucocorticoid-Induced Insulin Resistance - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible2 sourcesCan disrupted sleep and circadian rhythms contribute to insulin resistance?→Plausible6 sourcesCan reduced ALA conversion contribute to low EPA despite normal DHA?→